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THE ability of cortisone to expedite the induction, transplantability and
metastasis of various types of epidermal and connective-tissue tumours is still
somewhat debatable (see Baserga and Shubik, 1954; Ghadially and Green, 1954;
Piccagli et al., 1954, and Gillman et al., 1955 for critical reviews of relevant litera-
ture). There is, however, some evidence that cortisone administration may alter
somewhatthepathogenesis ofmethylcholanthrene-induced skintumours (Boutwell
and Rusch, 1953; Gillman et al., 1955).
A careful analysis of the literature indicates that discrepancies in the various
reported effects of cortisone on the induction, metastasis and transplantability of
tumours are largely attributable, firstly, to differences in the times of initiation
of cortisone treatment in relation to the application of carcinogens (Ghadially
and Green, 1954) and, secondly, to the type of tumour being investigated (see
Baserga and Shubik, 1954 for discussion). Thus, Baserga and Shubik who
administered cortisone during the "induction " and "developmental " stages of
skin carcinomas found that cortisone inhibited tumour development. Ghadially
and Green, on the other hand, found that:
"Local treatment with cortisone, from the commencement of 9: 10-
dimethyl-1: 2 benzanthracene painting inhibited papillomata formation in
the mouse skin, almost completely. Cortisone also produced this effect when
allowed to act during the "developmental " phase of carcinogenesis but was
quite ineffective when applied solely during the 'pre-induction' and
'induction ' phases."
We have previously reported that cortisone fails to suppress epithelial growth
or neoplasia ifgiven to wounded rabbits or carcinogen-treated mice before, during
and after wounding or methylcholanthrene treatment. However, we did find that
cortisone delays, although it does not completely inhibit, tumour formation in
mice, and also appears to alter somewhat the pathogenesis of the induced skin
carcinomas (Gillman, et al., 1955).
It is now generally conceded that cortisone depresses (but does not completely
inhibit) connective-tissue growth following wounding or other injuries (Ragan
et al., 1950; Baker and Whitaker, 1950; Selye, 1953; Baxter, Schiller and White-
side, 1951; Gillman and Penn, 1956) and suppresses the reactivity ofthe reticulo-
endothelial system, including its ability to manufacture antibodies (see Thomas,
1955, fororiginal findings and reviewofliterature). In our ownskinwound-healingCORTISONE AND METHYLCHOLANTHRENE TUMOURS
experiments in rabbits, we have found that the administration of cortisone, before
and during the healing of incised or excised wounds, depresses the regenerative
capacity of the connective tissues but does not completely suppress them.
In a previous briefreport from this laboratory it was indicated that because of
the intimate interdependence of epidermis and dermis during healing and tumour
genesis (Gillman etal., 1955 a,b, c; Gillman andPenn, 1956) the effects ofcortisone
on tumour induction in the skin, reported by us, may be attributable to the ability
of this steroid hormone to depress connective-tissue regeneration without simul-
taneously interfering with the multiplication of epidermal cells. In the light of
this view, the findings reported below are of a special interest for our hypothesis,
more especially, as will be indicated, the effects of cortisone treatment on tumour
genesis in the skin are somewhat different from its effects on primary lung tumours
simultaneously induced by topical application of methylcholanthrene (MCh).
MATERIAL AND METHODS
In a series of experiments one drop of 0 3 per cent MCh-solution (in acetone)
was applied with a dropper twice weekly to the sacral skin oftwo month-old albino
mice for a total of 20 applications (for details see Gillman, Hathorn and Penn,
1956).
In Experiment 1, fourteen days after the last MCh application, the mice were
divided into four groups, which received the following treatment:
I drop--thriceweekly--to the A. Cortisone-100 mg. in 1 c.c. 95 per cent alcohol 1 1 drop-thriceweekly-tothe
B. Alcohol-I1 drop 95 per cent previously MCh-treated area.
C. Cortisone-0-25 mg. in aqueous suspending medium Thrice weekly subcutaneous
D. Aqueous suspending medium alone, 0-25 c.c. injections.
In Experiment 2, thirty-three days after the last MCh application, the mice
were divided into three groups which received the following treatments:
1. Cortisone-100 mg. per c.c. in 95 per cent alcohol 1 drop-thrice weekly-to
2. Alcohol-95 per cent previously MCh-treated area.
3. No treatment after 20th application of MCh (" slow depilators "-see Gillman, Hathorn
and Penn, 1956).
In Experiment 3 mice received initially 20 acetone applications instead ofMCh,
and thirty-three days later received thrice weekly cortisone applications to the skin
as in Experiment 2.
Experiment 1 was terminated at 231 days, and Experiments 2 and 3 at 266
days after the first MCh application. All mice were killed by ether anaesthesia
when moribund, or at the conclusion of the experiments. Full post-mortem
examinations were conducted and careful notes were made of the macroscopic
appearances of the skin and lungs. Paraffin blocks were prepared of the treated
sacral skin in all instances, and of the lungs in each case, and other tissues when
deemed necessary. Serial sections were frequently made of lesions in the lungs
suspected of being neoplasms.
Finally, agroup ofuntreated stockmice ofthe same age asthose inExperiments
2 and 3, were sacrificed when 266 days old, in order to determine the spontaneous
incidence oflung tumours in our strain of mice under our experimental conditions.
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RESULTS
Skin tumours
Inthese experiments it was found that cortisone, administered after completion
of MCh treatment, topically in alcohol or by injection in aqueous suspending
medium, failed to alter the microscopically-determined incidence of skin tumours
as compared with the MCh-treated controls receiving alcohol topically or cortisone-
free suspending medium by injection. This failure of cortisone to suppress skin
tumourswasconsistentlyobservedwhetherornottumours werepresent atthetime
cortisone treatment was started. WVhether or not the alcohol, used as a solvent
forthe cortisone, operated as a slight co-carcinogen still remains tobedetermined.
Our findings relating to this aspect of the problem have been outlined elsewhere
(Gillman et al., 1955). It may be added also, that, in experiments not hitherto
reported in full, cortisone was not found to promote metastasis ofmacroscopically
obviousfungating skin carcinomata, as was apparently the case in the experiments
reported by Baserga and Shubik (1954).
Lung tumours
It has long been known that primary pulmonary adenomas can be induced in
mice by cutaneous applications of methylcholanthrene or other carcinogens
(Murphy and Sturm, 1925; Lorenz and Stewart, 1940; Morton and Mider, 1941).
The mechanism whereby cutaneously applied MCh promotes this type ofneoplasm
still unknown. Topical application of carcinogens has also recently been shown
to expedite urethane-induced pulmonary adenomata (Salaman and Roe, 1953).
A. Control Groups.-Twenty-eight mice in all the experiments were found to
have tumours of the lung. In two animals, microscopic examination revealed the
lung tumours to be squamous epitheliomata, and since these were found in mice
bearing large,locally infiltrating skin carcinomas, they were classifiedas metastases
(one each in the topical cortisone and topical alcohol groups).
The lung tumours in the remaining 26 experimental mice, together with those
occuring spontaneously in the one untreated stock mouse of the same age as the
experimental groups, were regarded as typical primary neoplasms, with micro-
scopic appearances distinct from those of the secondary carcinomas. On the basis
ofboth the macroscopic and microscopic criteria detailed by Grady and Stewart
(1940) these tumours were classified as primary pulmonary adenomata.
TABLE I.-Types of Skin Lesions associated with Primary Lung Tumours
Number ofmice with
Type of skin lesion. primary lung tumours.
Carcinoma . . . . 13
Carcinoma and sarcoma . . 2
Sarcoma . . . . . 3
Papillomas only . . . 3
Without skin lesions . . . 5
Total . . . . 26
The condition ofthe skin ofthemicebearingthese primarypulmonarytumours
is shown in Table I. From this table it will be seen that 5 mice with lung tumours
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had no detectable skin lesions at all, and that a further 3 mice had only benign
skin lesions. This tends to substantiate our opinion that the lung tumours in our
mice were indeed primary pulmonary adenomata.
TABLE II.-Incidence of Primary Lung Neoplasms
Incidence of
primary lung tumours.
Experiment Intitial Subsequent At 231 days. At 266 days
No. treatment. treatment. No. % No. %
Stockmice Nil . Nil . - - 1/13 8
3 . Acetone . Cortisone applications . - - 0/7 0
12 20 bi-weekly applica- Nil 5/10 50 1, 2
t of methylica
Alcohol applications 3/8 37 8/15 53
12 tions of methylcho- / 3 /5 5 1, 2 lanthrene (0 3°/ in Cortisone applications 0/7 0 6/18 33
1 acetone) Aq. susp. med. injections . 4/7 57
1 J Cortisone injections . 0/5 0 -
B. Effect of cortisone on incidence of primary lung tumours.-From Table II
it will be seen that in the experiments terminated at 231 days, cortisone, whether
administered byinjection orbytopicalapplication appearedto suppress completely
the development of primary lung tumours. At this time no tumours were found
in any ofthe 12 cortisone treated mice as compared with 7 out of 15 ofthe controls.
However, when the findings in Experiment 2 (terminated at 266 days) are
considered it is at once apparent that cortisone did not entirely prevent the
development of these tumours. However, cortisone did seem significantly to
delay their onset to beyond the 231st day of the experiments. The fact that the
experiment was not continued for longer than 266 days may alone account for
the lower incidence of lung tumours in the cortisone treated mice, even in the
second experiment.
Whether or not cortisone, in addition to delaying their onset, would diminish
the ultimate incidence of lung tumours if the experiments had been continued for
much longer can only be determined by experiments of even longer duration than
those reported upon here (see below).
DISCUSSION
In the present experiments cortisone was initially applied only during the
"developmental "phase of carcinogenesis, and well after the "induction phase"
had been completed. Our findings in the skins of our mice are, therefore, not in
accordance with those reported by Ghadially and Green (1954), nor with those
of Baker and Whitaker (1949), Baserga and Shubik (1954) or Engelbreth-Holm
and Asboe-Hansen (1953). However, our observations do support those of Rusch
(1953) and of Boutwell and Rusch (1953). Nevertheless, it should be carefully
noted, since it merits such special attention, that all the investigators who reported
that cortisone suppresses experimentally-induced skin neoplasia, conducted their
experiments for only relatively short periods, ranging from 21 days (Baker and
Whitaker, 1949) to a maximum of 26 weeks (Piccagli et al., 1954), as opposed to
the experiments reported on by Boutwell and Rusch, and by ourselves, which
extended over very much longer periods (up to 33 and 38 weeks in our own
experiments).
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As indicated above, there is ample evidence in the literature to demonstrate
that although cortisone retards connective-tissue regeneration, healing of wounds
is, nevertheless, ultimately satisfactorily achieved even in cortisone-treated
subjects (human and animal). We have already noted elsewhere (Gillman et al.,
1955) that cortisone suppresses and alters the dermal reactions usually encountered
in mice following hair plucking or those associated with the epidermal neoplasia
induced by MCh. However, epidermal malignancy ultimately occurred in our
mice, albeitthe pathogenesis ofthese tumours was apparently altered bythe corti-
sone treatment administered topically or by subcutaneous injection. These
earlier observations from our laboratory are confirmed by the presently reported
experiments, in respect of the skin tumours. We may also add that in our mice,
both in the present and in several other series of experiments (some reported on
in the literature and others not), we have not been able to confirm the finding of
Baserga and Shubik (1954) that cortisone treatment promotes metastasis of
fungating methylcholanthrene induced skin carcinomas.
Regarding the primary pulmonary tumours which were encountered incident-
ally in our mice-once more our findings indicate that cortisone delays but does
not entirely suppress the development of these tumours. Had we studied only
animals killed at 231 days of the experiment then it would certainly have seemed
that cortisone treatment had completely suppressed the induction of primary
pulmonary tumours by cutaneous applications of MCh. However, the results of
a subsequent experiment, of longer duration, indicated that cortisone does not
completely suppress primary pulmonary adenomatosis, but rather significantly
delays the onset of such tumours, which nevertheless appear in greater numbers
than among control completely untreated stock mice of similar ages.
Cortisone has been shown by several investigators, including ourselves, to be
incapable of suppressing regeneration of the epidermis during wound healing
(Lattes et al., 1953; Gillman et al., 1955). However, it is generally agreed (see
above) that cortisone delays connective-tissue regeneration in healing or inflam-
mation andis apparently not asinhibitory tothegrowth oftransplanted connective-
tissue tumours as to epithelial tumours (Baserga and Shubik, 1954).
Like other investigators (Orr, 1939; Marchant and Orr, 1953; Vernoni, 1951)
we have repeatedly drawn attention to the possible role of the connective tissues
in epidermal neoplasia (Gillman et al., 1955). It seems possible, at least, that
cortisone delays epithelial tumour formation and growth indirectly via its effects
on the associated connective tissues. This may explain the retardation of tumour
induction, both in the skin and in the lungs of our MCh-treated mice receiving
cortisone.
Another explanation may be suggested to account for the apparently more
marked (or more prolonged) retarding action of cortisone on tumour induction
in the lung as compared with the skin. As shown by Stewart (1953) metastases of
primary pulmonary adenomata often exhibit sarcomatous patterns of growth.
Moreover, as finally established by Stewart, Grady and Andervont (1947) these
tumours frequently undergo partial or complete sarcomatous transformations on
serial transplantation. To the four theories advanced by Stewart (1953) to account
forthisremarkable changeintheseapparentlyglandularepitheliallungtumours, yet
another possiblity might be added. This fifth theoretical explanation is that the
primary lung tumours arise from cells which are derived, embryologically, from
mesenchyme. If this ultimately proves to be the case, then it might be expected,
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in- view of the special suppressive effects of cortisone on other mesenchymal
derivatives, thatthedevelopment oflungtumourswouldalsobemarkedlyinhibited
by this hormone. This possibility may also explain the sarcomatous transforma-
tion of these tumours on transplantation.
Our findings relating to the effects of cortisone on the skin and lung tumour
induction provide a basis for suggesting that more intensive study of the role of
connective tissues in the histogenesis of neoplasms is merited. It also seems
reasonable to suggest that, by using cortisone, it may yet prove possible to
illuminate several aspects of the origins, growth and powers ofdifferentiation of
metastases and/or transplants of primary pulmonary adenomas in mice.
SUMMARY AND CONCLUSIONS
1. The effects of topically applied and of injected cortisone on the induction
of skin and primary lung tumours by methylcholanthrene have been examined.
2. Cortisone administered in the present experiments only during the
"developmental phase" of carcinogenesis, delayed but did not completely
suppress the appearance of skin and lung tumours. The retarding effects of corti-
sone on tumour induction, following topically applied MCh, was more marked in
the case of the lung than the skin.
3. Discrepancies in the literature, relating to the action ofcortisone on tumour
induction are reviewed and attributed: (a) to differences in the time of initiation
of cortisone administration relative to treatment with carcinogen, and (b) to the
fact that in many instances the full effects of cortisone on tumorigenesis could
not be assessed because the experiments reported on by others were not conducted
for long enough.
4. Comparisons have been drawn between the action ofcortisone on epithelium
and on connective tissue during wound healing, hair growth and tumorigenesis.
The conclusion was drawn that the ability of cortisone to retard tumour induction
may be due indirectly to the depressive effects of this hormone on the connective
tissues. Some possible implications of this conclusion are discussed for under-
standing tumorigenesis in general, and in particular, the origin and the peculiari-
ties ofthe growth ofmetastases and transplants ofprimary pulmonary adenomas.
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